Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
Not yet recruitingOBSERVATIONAL
Enrollment
600
Participants
Timeline
Start Date
April 1, 2024
Primary Completion Date
April 1, 2028
Study Completion Date
April 1, 2028
Conditions
Liver TransplantationHepatocellular CarcinomaAlpha-FetoproteinProtein Induced by Vitamin K Absence or Antagonist-II
All Listed Sponsors
collaborator
Shulan (Hangzhou) Hospital
OTHER
lead
Zhejiang University
OTHER
NCT06331260 - Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter